Coupé VM - Search Results

1

HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness.

Coupé VM, van Ginkel J, de Melker HE, Snijders PJ, Meijer CJ, Berkhof J. Coupé VM, et al. Int J Cancer. 2009 Feb 15;124(4):970-8. doi: 10.1002/ijc.24000. Int J Cancer. 2009. PMID: 19035448 Free article.

2

HPV16 and increased risk of recurrence after treatment for CIN.

Gök M, Coupé VM, Berkhof J, Verheijen RH, Helmerhorst TJ, Hogewoning CJ, Snijders PJ, Meijer CJ. Gök M, et al. Among authors: coupe vm. Gynecol Oncol. 2007 Feb;104(2):273-5. doi: 10.1016/j.ygyno.2006.10.011. Epub 2006 Dec 8. Gynecol Oncol. 2007. PMID: 17157365

3

Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia.

Coupé VM, Berkhof J, Verheijen RH, Meijer CJ. Coupé VM, et al. BJOG. 2007 Apr;114(4):416-24. doi: 10.1111/j.1471-0528.2007.01265.x. BJOG. 2007. PMID: 17378816

4

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening.

Coupé VM, Berkhof J, Bulkmans NW, Snijders PJ, Meijer CJ. Coupé VM, et al. Br J Cancer. 2008 Feb 12;98(3):646-51. doi: 10.1038/sj.bjc.6604162. Epub 2008 Jan 8. Br J Cancer. 2008. PMID: 18182990 Free PMC article.

5

Human papillomavirus testing improves follow-up after treatment for cervical intraepithelial neoplasia.

Coupé VM, Berkhof J. Coupé VM, et al. Womens Health (Lond). 2008 Mar;4(2):103-5. doi: 10.2217/17455057.4.2.103. Womens Health (Lond). 2008. PMID: 19072507 Free article. No abstract available.

6

How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.

Coupé VM, de Melker HE, Snijders PJ, Meijer CJ, Berkhof J. Coupé VM, et al. Vaccine. 2009 Aug 13;27(37):5111-9. doi: 10.1016/j.vaccine.2009.06.043. Epub 2009 Jun 28. Vaccine. 2009. PMID: 19567242

7

Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

Coupé VM, Meijer CJ, Berkhof J. Coupé VM, et al. J Natl Cancer Inst. 2010 Mar 3;102(5):358; author reply 358. doi: 10.1093/jnci/djp372. Epub 2009 Oct 27. J Natl Cancer Inst. 2010. PMID: 19861306 No abstract available.

8

Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test.

Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, Van Heukelem HA, Loffeld RJ, Wesdorp IC, Van Wanrooij RL, De Baaij L, Mutsaers ER, van der Reijt S, Coupe VM, Berkhof J, Bouman AA, Meijer GA, Mulder CJ. Oort FA, et al. Among authors: coupe vm. Aliment Pharmacol Ther. 2010 Feb 1;31(3):432-9. doi: 10.1111/j.1365-2036.2009.04184.x. Epub 2009 Oct 29. Aliment Pharmacol Ther. 2010. PMID: 19878150 Free article.

9

The health and economic effects of HPV DNA screening in The Netherlands.

Berkhof J, Coupé VM, Bogaards JA, van Kemenade FJ, Helmerhorst TJ, Snijders PJ, Meijer CJ. Berkhof J, et al. Among authors: coupe vm. Int J Cancer. 2010 Nov 1;127(9):2147-58. doi: 10.1002/ijc.25211. Int J Cancer. 2010. PMID: 20112339 Free article.

10

Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus.

Bogaards JA, Xiridou M, Coupé VM, Meijer CJ, Wallinga J, Berkhof J. Bogaards JA, et al. Among authors: coupe vm. Am J Epidemiol. 2010 Apr 1;171(7):817-25. doi: 10.1093/aje/kwp466. Epub 2010 Mar 15. Am J Epidemiol. 2010. PMID: 20231211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page